Literature DB >> 20215136

Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa.

A Italiano, C Delcambre, I Hostein, A L Cazeau, M Marty, A Avril, J-M Coindre, B Bui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20215136     DOI： 10.1093/annonc/mdq044

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  36 in total

1.  PEComa of soft tissues can mimic lymph node relapse in patients with history of testicular seminoma.

Authors:  Gabriele Guglielmetti; Paolo De Angelis; Paolo Mondino; Carlo Terrone; Alessandro Volpe
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

Review 2.  Histology-specific therapy for advanced soft tissue sarcoma and benign connective tissue tumors.

Authors:  Ann W Silk; Scott M Schuetze
Journal:  Curr Treat Options Oncol       Date:  2012-09

3.  Long-lasting stable disease with mTOR inhibitor treatment in a patient with a perivascular epithelioid cell tumor: A case report and literature review.

Authors:  Ezequiel Flechter; Yaniv Zohar; Ludmila Guralnik; Maria Passhak; Gil Bar Sela
Journal:  Oncol Lett       Date:  2016-10-06       Impact factor: 2.967

4.  Malignant epithelioid angiomyolipoma: tumor and metabolic response to everolimus as evaluated with positron emission tomography.

Authors:  Eliney Faria; Francesco Turturro; Priya Rao; Surena F Matin
Journal:  Clin Genitourin Cancer       Date:  2013-06-20       Impact factor: 2.872

5.  Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates.

Authors:  Mark A Dickson; Gary K Schwartz; Cristina R Antonescu; David J Kwiatkowski; Izabela A Malinowska
Journal:  Int J Cancer       Date:  2012-09-21       Impact factor: 7.396

6.  Combination targeted therapy of VEGFR inhibitor, sorafenib, with an mTOR inhibitor, sirolimus induced a remakable response of rapid progressive Uterine PEComa.

Authors:  Fang Gao; Chengsuo Huang; Yiping Zhang; Ruirui Sun; Yujie Zhang; Huijun Wang; Shu Zhang
Journal:  Cancer Biol Ther       Date:  2016-03-30       Impact factor: 4.742

7.  Hormonal manipulation with letrozole in the treatment of metastatic malignant pecoma.

Authors:  P Le; A Garg; G Brandao; A Abu-Sanad; L Panasci
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

Review 8.  Systemic treatment of soft-tissue sarcoma-gold standard and novel therapies.

Authors:  Mark Linch; Aisha B Miah; Khin Thway; Ian R Judson; Charlotte Benson
Journal:  Nat Rev Clin Oncol       Date:  2014-03-18       Impact factor: 66.675

Review 9.  VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature.

Authors:  Aikaterini Liapi; Patrice Mathevet; Fernanda G Herrera; Delfyne Hastir; Apostolos Sarivalasis
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244

10.  Perivascular Epithelioid Cell Tumor of the Buttock Region.

Authors:  Rafey Rehman; Mariam Aoun; Ronald Levitin; Thomas Quinn; Peyman Kabolizadeh
Journal:  Cureus       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.